Serine Protease Variant Mutations for Thermal Stability and Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing serine proteases lack sufficient thermal stability and activity for enhanced industrial applications.
Innovation Solution
A serine protease variant is developed by substituting specific amino acids at positions 180 and/or 331 or 361 with tyrosine, glutamic acid, histidine, leucine, methionine, asparagine, glutamine, or tryptophan, maintaining at least 75% sequence homology to SEQ ID NO: 10 or 7, and is produced using a Bacillus sp. microorganism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If amino acid substitution is performed to improve thermal stability and activity, then enzyme performance is enhanced, but protein structure complexity increases
Solution Approach 1:
The patent applies local quality by performing site-directed mutagenesis at specific positions (180, 331, 361) of the serine protease sequence. Instead of random mutations throughout the protein, the invention focuses on substituting amino acids only at these critical positions to improve thermal stability and activity, thereby enhancing performance while minimizing unnecessary structural complexity
Solution Approach 2:
The patent employs parameter changes by substituting specific amino acid residues at defined positions in the serine protease sequence. This involves changing the chemical parameters (amino acid type) at specific locations to optimize enzyme performance, achieving improved thermal stability and catalytic activity through controlled sequence modification
2Productivity
If amino acid substitution is performed to enhance activity, then enzymatic performance improves, but manufacturing complexity increases
Solution Approach 1:
The invention applies local quality by targeting specific positions (180, 331, 361) for amino acid substitution to enhance enzymatic activity. This localized approach allows for improved productivity through focused mutations at critical residues, while simplifying the manufacturing process compared to random mutagenesis or whole-protein redesign
Solution Approach 2:
The patent applies preliminary action by pre-identifying the critical positions (180, 331, 361) in the serine protease sequence that are most likely to influence activity and stability. This preliminary analysis of sequence structure and functional importance allows for targeted mutagenesis, reducing manufacturing complexity by avoiding trial-and-error approaches
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The variant exhibits superior activity and stability, enabling diverse industrial applications including feed and food production, leather processing, and contact lens cleaning.
Implementation Method 1
a serine protease variant, in which an amino acid corresponding to position 180 of SEQ ID NO: 10 is substituted with a different amino acid
Data Source
AI summary
The present disclosure relates to a novel serine protease variant.


